Statin exposure and the risk for herpes zoster: implications for public health
Br J Dermatol
.
2016 Dec;175(6):1137-1138.
doi: 10.1111/bjd.15031.
Authors
G Shalom
1
2
,
A D Cohen
3
4
Affiliations
1
Department of Dermatology and Venereology, Soroka Medical Center, Beer-Sheva, Israel.
2
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
3
Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
4
Chief Physician's Office, Department of Quality Measurements and Research, Clalit Health Services, Tel Aviv, Israel.
PMID:
27996130
DOI:
10.1111/bjd.15031
No abstract available
MeSH terms
Herpes Zoster
Herpesvirus 3, Human
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Public Health*
Risk
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors